Skip to content
  • CONTACT
  • SUBSCRIBE
FacebookTwitterInstagramPinterestLinkedIn
Voyageur Pharmaceuticals Logo Voyageur Pharmaceuticals Logo Voyageur Pharmaceuticals Logo
  • OUR COMPANY
    • Our Company
    • Corporate Strategy
    • Officers & Directors
    • CEO’s Posts
    • Responsible Mining
  • PHARMACEUTICALS
    • Manufacturing Facilities
    • Our Products
    • Barium & Iodine Contrast Market and Sales Strategy
  • OUR PROPERTIES
    • Our Properties
    • Lithium & Iodine
    • Frances Creek High Grade Discovery
    • Jubilee Mountain
    • Pedley Mountain
    • US Assets
    • Geology & Reports
    • Project Gallery
  • INVESTORS CENTRE
    • Investors Centre
    • Lithium & Iodine
    • Barite
    • Capital Structure
    • Ownership Opportunity
    • Corporate Presentations
    • Why Invest?
    • Common Questions
  • NEWS
  • CONTACT

Voyageur Announces New CFO, Issuance of Shares and Warrants to Extinguish Debt, and Issuance of Stock Options

Voyageur Announces New CFO, Issuance of Shares and Warrants to Extinguish Debt, and Issuance of Stock Options

brent_adm2020-02-24T09:49:07-07:00

Office: + 403 923 5944
info@vpharma.ca

Dome Tower
1600, 333 7 Ave. S.W.
Calgary, Alberta T2P 2Z1

Privacy Policy | Disclaimer

Go to Top